805 filings
Page 4 of 41
8-A12B/A
j83x6gja lm2ah
12 Feb 21
Registration of securities on exchange (amended)
9:22am
8-K
vmurb2fzq2
12 Feb 21
Vericel Announces Termination of Shareholder Rights Agreement
8:56am
8-K
fulv37ph q2t
25 Jan 21
Vericel Announces Appointment of Joe Mara as Chief Financial Officer
8:35am
8-K
vjdvtz
11 Jan 21
Vericel Announces Preliminary Fourth-Quarter and Full-Year 2020 Financial Results and Provides Business Updates
7:30am
8-K
r3q19nsgcb
5 Nov 20
Vericel Reports Record Third Quarter Revenues and Net Income
9:27am
8-K
ujrhm3
14 Oct 20
Vericel Announces Preliminary Third Quarter 2020 Total Net Revenues of $32 Million
8:00am
8-K
a7f255
16 Sep 20
Vericel Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns
4:05pm
8-K
846df09t6xnc628wsc
8 Sep 20
Departure of Directors or Certain Officers
4:04pm
S-8
kqtj xad73
6 Aug 20
Registration of securities for employees
5:04pm
8-K
eijm1 pj3
5 Aug 20
Vericel Reports Second Quarter 2020 Financial Results
8:45am
8-K
10vdm327o187p8dgmxxq
9 Jul 20
Vericel Announces Preliminary Second Quarter 2020 Financial Results and Provides Business Updates
4:12pm
8-K
g7v ia0d9r
30 Jun 20
Vericel Announces Submission of Biologics License Application to the FDA for NexoBrid for the Treatment of Severe Thermal Burns
4:08pm
8-K
3pwv2mja3c7oixt
5 May 20
Vericel Reports First Quarter 2020 Financial Results
8:19am
8-K
n0mamu
1 May 20
Departure of Directors or Certain Officers
4:10pm
DEFA14A
d78pg8l2
10 Apr 20
Additional proxy soliciting materials
9:10am
8-K
megigw9r5
2 Apr 20
Vericel Provides Business and Financial Updates
9:02am